Dexamphetamine

右旋苯丙胺

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameDexamphetamine
Drug Alias NameDexamphetamine Sulfate硫酸右旋苯丙胺硫酸苯丙胺右苯丙胺
ClassificationSmall molecules
Mechanisms of ActionCentral nervous system stimulants
TargetsNot applicable
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityCocaine-Related DisordersAlcoholic Intoxication +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesImpax Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical CenterThe Netherlands Cancer InstituteLeiden University Medical Center
Inactive CompaniesVallon Pharmaceuticals Inc
Active IndicationsCocaine-Related DisordersAlcoholic IntoxicationFatigue +[5] 
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksKEGG